Oncology/Hematology Market Research Reports & Industry Analysis
Oncology/Hematology Industry Research & Market Reports
-
Cervical Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... provides an overview of the Cervical Cancer (Oncology) pipeline landscape. Cervical cancer occurs when abnormal cells on the cervix grow out of control. Most cervical cancer is caused by a virus called human papillomavirus, or ... Read More
-
Middle-East and Africa Cancer Vaccines Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)
... period. Global health care services have been severely impacted by the COVID-19 pandemic. Particularly in low-resource countries, the pandemic has disrupted cancer services. As per the article published in October 2021 titled, 'Impact of the ... Read More
-
Cancer Monoclonal Antibodies Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)
... is an unprecedented health concern that is impacting the tumor ablation market. For instance, a study titled ‘Impact of the COVID-19 Pandemic on Cancer Care: A Global Collaborative Study’ in 2020 reported that A total ... Read More
-
Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... Leukemia (ALL, Acute Lymphoblastic Leukemia) - Drugs In Development, 2022, provides an overview of the Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) (Oncology) pipeline landscape. Acute lymphocytic leukemia (ALL) is the cancer of the white ... Read More
-
Targeted Cancer Therapy Market - Growth, Trends, Covid-19 Impact, And Forecasts (2022 - 2027)
... COVID-19 pandemic has affected the healthcare systems globally and significantly impacted the targeted cancer therapy market. As per the article published in Cancer Connect 2020, doctors from Dana Farber Cancer Institute determined that during the ... Read More
-
Europe Cancer Therapeutics Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)
... of the global spread of COVID-19 in early 2020, patients with cancer were designated as a particularly vulnerable subgroup of the population. Cancer patients have been reported to be both at increased risk of contracting ... Read More
-
Metastatic Melanoma Drugs Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)
... had a substantial impact on the metastatic melanoma drugs market initially. The strict lockdowns and government regulations intended to slow down the spread of COVID-19 resulted in a decrease in the treatment of cancer patients ... Read More
-
Cancer Biomarkers Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)
... healthcare systems and resulted in the interruption of usual care in many healthcare facilities, exposing vulnerable patients with cancer to significant risks. The COVID-19 pandemic had a negative impact on the cancer biomarkers market, owing ... Read More
-
HER-2 Negative Breast Cancer Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)
... 20.442.3 million by 2027, registering a CAGR of 10.08% over the forecast period. The emergence of the COVID-19 pandemic had an adverse effect on the world economy and healthcare system. The lockdown all over the ... Read More
-
Cancer Vaccines Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)
... 2027 with a CAGR of 11.54% during the forecast period (2022 - 2027). The outbreak of the COVID-19 pandemic had an adverse effect on the global economy and healthcare system. Pharmaceuticals, medical gadgets, and biotechnological ... Read More
-
Esophageal Cancer Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
... be more than 440,000 diagnosed prevalent cases of esophageal cancer across 16 pharmaceutical markets. Currently there are four leading marketed innovator drugs for the treatment of esophageal cancer, mostly programmed cell death protein 1 (PD1) ... Read More
-
Global Pituitary Cancer Market - 2022-2029
... 9.4% during the forecast period (2022-2029). Pituitary cancer is characterized by abnormal growth in the pituitary gland. It affects the functioning of the pituitary gland and may cause an increased or decreased level of pituitary ... Read More
-
Cancer Diagnostics Market (Test Type: Tumor Biomarker Tests, Imaging, Endoscopy, and Biopsy; End-user: Hospitals, Ambulatory Surgical Centers, Diagnostic Laboratories, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031
... – Scope of Report TMR’s report on the global cancer diagnostics market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during ... Read More
-
Global Nasopharyngeal Cancer Market - 2022-2029
... % during the forecast period (2022-2029). Nasopharyngeal cancer is a rare therapy of malignant cancer that appears in the nasopharynx. It is the upper part of the throat behind the nose. The nasopharynx is situated ... Read More
-
Global Chronic Lymphocytic Leukemia Therapeutics Market - 2022-2029
... a CAGR of 7.90% during the forecast period (2022-2029). Chronic Lymphocytic Leukemia (CLL) is a hematological malignancy marked by excessive proliferation of abnormal white blood cells. CLL predominantly affects the B-cell lymphocytes involved in producing ... Read More
-
Global Castrate Resistant Prostate Cancer Therapeutics Market - 2022-2029
... growing at a CAGR of 8.4% during the forecast period (2022-2029). Castration-resistant prostate cancer is stated as prostate cancer that is scattered to other parts of the body. Several risk factors for castration-resistant prostate cancer ... Read More
-
Global Cancer Molecular Diagnostics Market - 2022-2029
... CAGR of 6.30% during the forecast period (2022-2029). Cancer molecular diagnostics include the detection, diagnosis, sub-classification, prognosis, and monitoring response to therapy. These techniques identify the alterations in DNA or RNA sequences, associated with cancer. ... Read More
-
Global Oncology Therapy Market - 2022-2029
... during the forecast period (2022-2029). Cancer therapies are medications designed to limit cancer growth and proliferation by interfering with specific molecules involved in the growth and expansion of malignant cells, such as proteins or DNA. ... Read More
-
Companion Diagnostics for Oncology Market Size & Share 2022 Outlook Report With COVID-19 Updated Analysis Forecast till 2030
... change the market dynamics of the industry. It provides an in-depth analysis of the market segments which include types, applications, and competitor analysis. The global Companion Diagnostics for Oncology market size is growing at a ... Read More
-
Global Hematology Market - 2022-2029
... % during the forecast period (2022-2029). Hematology is a branch of medicine that deals with diagnosing, treating, and preventing blood, blood-forming organs, and blood diseases such as blood cancer, anemia, hemophilia, and blood clots. Hematological ... Read More
-
Global Cervical Cancer Treatment Market - 2022-2029
... cervix is the lower part of the uterus that connects to the vagina. Cervical cancer begins in the cells of the cervix. Most cervical malignancies are caused by strains of the sexually transmitted pathogen, Human ... Read More
-
Global Cancer Vaccines Market - 2022-2029
... forecast period (2022-2029). Cancer is a malignant tumor caused by uncontrollable cell development in the body. It can be treated with a variety of drugs and vaccinations. Vaccines are widely classified as either preventative or ... Read More
-
Nanomedicine Market Size, Share & Trends Analysis Report By Application (Drug Delivery), By Indication (Clinical Oncology, Infectious Diseases), By Molecule Type (Nanoparticles), By Region And Segment Forecasts, 2022 - 2030
... The global nanomedicine market is expected to reach USD 427.18 billion by 2030, registering a CAGR of 11.7% during the forecast period, according to a new report by Grand View Research, Inc. The advantages of ... Read More
-
Global Cancer Treatment Drugs Market - 2022-2029
... of 10.6% during the forecast period (2022-2029). The widespread prevalence of cancer leads to the rapid development of cancer treatment drugs. Various drugs have received regulatory approval from the USFDA (Food and Drug Administration) the ... Read More
-
Global Skin Cancer Market - 2022-2029
... to abnormal growth of skin cells. It is estimated that 90% of skin cancer is caused majorly due to solar and artificial ultraviolet radiation (UV). Ultraviolet radiation is a primary carcinogen that results in UV-induced ... Read More
Research Assistance
